Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06099366
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2023-10-18
Brief Title:
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Sponsor:
Hee Young Ju
Organization:
Samsung Medical Center
Study Overview
Official Title:
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aim of this study is to investigate the outcome of NGS MRD based risk stratified treatment for standard risk acute lymphoblastic leukemia in children and adolescents
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None